MFIM
BEAT

Mesirow Financial Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Mesirow Financial Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,434
Closed -$175K – 137
2020
Q4 		$175K Sell
2,434
-5,045
-67% -$264K 0.55% 70
2020
Q3 		$341K Buy
7,479
+964
+15% +$40.3K 1.46% 28
2020
Q2 		$294K Sell
6,515
-1,202
-16% -$53.9K 1.38% 40
2020
Q1 		$297K Sell
7,717
-2,648
-26% -$122K 1.87% 5
2019
Q4 		$480K Sell
10,365
-347
-3% -$15K 2.03% 7
2019
Q3 		$436K Sell
10,712
-677
-6% -$29.2K 1.83% 21
2019
Q2 		$541K Buy
11,389
+5,873
+106% +$309K 1.97% 22
2019
Q1 		$345K Sell
5,516
-539
-9% -$37K 1.37% 40
2018
Q4 		$362K Sell
6,055
-1,597
-21% -$95.9K 2.34% 11
2018
Q3 		$493K Sell
7,652
-3,867
-34% -$216K 2.54% 6
2018
Q2 		$518K Sell
11,519
-2,076
-15% -$82.8K 2.3% 10
2018
Q1 		$422K Sell
13,595
-199
-1% -$6.54K 1.78% 24
2017
Q4 		$412K Buy
+13,794
New +$399K 1.87% 22

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Mesirow Financial Investment Management's BEAT Position: Q1 2021 in Review

Mesirow Financial Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 2,434 shares — an estimated $175K sold.

Mesirow Financial Investment Management first reported a position in BEAT in Q4 2017 and held it in 13 quarters. The position peaked at $541K in Q2 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Mesirow Financial Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 2,434 BioTelemetry, Inc. shares in Q1 2021, an estimated $175K.
  • Mesirow Financial Investment Management first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 13 quarters.
  • Mesirow Financial Investment Management's BioTelemetry, Inc. position peaked at $541K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q1 2021, filed 14 Apr 2021.